
Sign up to save your podcasts
Or
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
4.9
5656 ratings
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
136 Listeners
17 Listeners
30 Listeners
13 Listeners
71 Listeners
13 Listeners
76 Listeners
0 Listeners
323 Listeners
116 Listeners
501 Listeners
57 Listeners
3,334 Listeners
200 Listeners
44 Listeners
21 Listeners
366 Listeners
185 Listeners
42 Listeners
0 Listeners